Article Text

Download PDFPDF

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients
  1. P B Jeppesen1,
  2. E L Sanguinetti2,
  3. A Buchman3,
  4. L Howard4,
  5. J S Scolapio5,
  6. T R Ziegler6,
  7. J Gregory2,
  8. K A Tappenden7,
  9. J Holst8,
  10. P B Mortensen1
  1. 1Department of Medicine CA-2121, Section of Gastroenterology, Rigshospitalet, University Hospital of Copenhagen, Denmark
  2. 2NPS Pharmaceuticals, Salt Lake City, UT, USA
  3. 3Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
  4. 4Division of Gastroenterology and Nutrition, Albany Medical College, Albany, NY, USA
  5. 5Mayo Clinic, Jacksonville, FL, USA
  6. 6Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  7. 7Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL, USA
  8. 8Panum Institute, Copenhagen, Denmark
  1. Correspondence to:
    Dr P Bekker Jeppesen
    Department of Medicine CA-2121, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; Bekkerdadlnet.dk

Statistics from Altmetric.com

Supplementary materials

  • Competing interests: EL Sanguinetti and J Gregory are employees of NPS Pharmaceuticals Inc. PB Jeppesen, A Buchman, L Howard, T R Ziegler, K A Tappenden, J Holst, and P B Mortensen have served as consultants and received research support from NPS Pharmaceuticals Inc. J S Scolapio has no competing interests.

    Footnotes

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Linked Articles

      • Robin Spiller